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http://dx.doi.org/10.1016/j.jds.2013.0Abstract Myoepithelioma is a rare form of salivary gland tumor composed entirely of myoe-
pithelial cells. This tumor was formerly considered to be a subtype of pleomorphic adenoma;
however, in the 1991 World Health Organization classification, it is listed as an independent
entity. The most favorable site of occurrence of myoepithelioma is the parotid gland. Here,
we report an extremely rare case of myoepithelioma of the upper lip. A 56-year-old woman
presented with a painless mass on her upper lip. Magnetic resonance imaging revealed a
23 mm  18 mm well-defined ovoid tumor. A benign minor salivary gland tumor was clinically
suspected, and the patient underwent complete resection of the tumor under general anes-
thesia. The tumor was histopathologically diagnosed as a benign myoepithelioma of the minor
salivary gland. Immunohistochemically, the tumor cells were positive for S-100 protein, AE1/
AE3, CAM5.2, CK7, vimentin, and calponin, confirming the morphologic diagnosis of myoepithe-
lioma. The patient’s postoperative clinical course was uneventful, and satisfactory results
were obtained both functionally and esthetically. To the best of our knowledge, this is the
sixth case of myoepithelioma of the upper lip reported in English-language research.
Copyright ª 2013, Association for Dental Sciences of the Republic of China. Published by
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Myoepithelial cells are ectoderm-derived contractile cells
that exhibit both epithelial and smooth muscle properties.
There are myoepithelial cells in salivary glands and other
exocrine organs situated between the basal lamina and the
acinar and ductal cells.1 Sheldon first used the term
myoepithelioma to describe those rare benign tumors
composed entirely of myoepithelioma cells that account for
less than 1% of all salivary gland tumors.2 The most common
site for salivary gland myoepitheliomas is the parotid gland,
but this tumor can also arise from the submandibular gland
and intraoral minor salivary gland.3e5 Because myoepithe-
lioma cells are difficult to identify on routine microscopic
preparations, analysis of the expression of cytoplasmic fil-
aments and ultrastructural features of these cells is
important for identifying the criteria providing a diagnosis
of myoepithelioma.6,7 Here, we describe an extremely rare
case of myoepithelioma of the upper lip that was success-
fully treated by surgical excision. To the best of our
knowledge, only five cases have been reported in the
English-language literature to date.8e10
Case report
On June 11, 2007, a 56-year-old Japanese woman was
referred to our clinic with a painless mass on her upper lip
that had gradually increased in size over a period of 3 years.
Her medical history was noncontributory. On physical ex-
amination, a soybean-sized, hard, mobile, and nontender
submucosal mass was observed on the left side of her upper
lip (Fig. 1). There were no palpable cervical lymph nodes.
Magnetic resonance imaging (MRI) revealed a
23 mm  18 mm well-defined, ovoid tumor. The peripheral
area of the tumor was uniformly thickly enhanced, while
the central area showed a partially cystic structure. No
absorption or destruction of the maxillary bone was
observed (Fig. 2). Based on these findings, a benign minor
salivary gland tumor was clinically suspected.
On July 5, 2007, the patient underwent tumor excision
under general anesthesia. During the surgery, rapid path-
ologic examination using frozen sections suggested a diag-
nosis of myoepithelioma. Because an increased nuclearFigure 1 A mass was observed on the left side of the pa-
tient’s upper lip.
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resected with a safety margin of 5 mm. The surgical defect
was covered by an artificial dermis.
On gross inspection, the resected tumor had a smooth
surface and was well-circumscribed and encapsulated
(Fig. 3). The cut surface of the tumor appeared solid, ho-
mogeneous, and white in color. Microscopically, the tumor
was composed of myoepithelial cells. The parenchyma also
contained clear cells and epithelial cells with a myxoid
matrix (Fig. 3). There was a very small number of nuclear
divisions (Fig. 3). Immunohistochemically (Table 1), the
tumor epithelioid cells were diffusely and strongly immu-
noreactive for S-100 protein and cytokeratins (AE1/AE3,
CAM5.2, and CK7). Most of the cells were also reactive for
both vimentin and calponin. However, they were negative
for a-smooth muscle actin and p63 (Fig. 4). The prolifera-
tive index Ki-67 was about 3% (Fig. 5).
The patient’s postoperative clinical course was un-
eventful. Neither clinical findings nor MRI scans have shown
any tumor recurrence over the intervening period of about
4 years.
Discussion
The diagnostic term myoepithelioma was first used by
Sheldon in 1943,2 but the tumor was reclassified as an in-
dependent entity in 1991 in the World Health Organization
international classification of salivary gland tumors.5
Myoepithelioma occurs in both men and women, most
frequently between 30 and 40 years of age, but these tu-
mors have been observed over a very wide age range from
children to the elderly.11 Like pleomorphic adenoma,
myoepithelioma frequently arises in the parotid gland,
which accounts for approximately 40% of cases, followed by
the palatine glands (approximately 21%). However, myoe-
pitheliomas of the lip are extremely rare.
Myoepithelioma presents as a solid tumor with a distinct
peripheral border. The core is white to yellowish or white in
color. The tumor becomes semi-translucent when myxoid
extracellular matrix is abundantly present.
Histologically, myoepithelioma is normally covered by a
fibrous membrane, but when it originates in a minor sali-
vary gland, the membrane is sometimes incomplete. The
parenchyma exhibits a diverse histologic profile depending
on morphologic variations in the neoplastic myoepithelial
cells and tissue architecture.12,13 According to Dardick et
al,14 epithelioid or epithelial cells account for 45.0% of the
main body of the tumor, followed, in order, by spindle cells
(32.5%), plasmacytoid cells (7.5%), and clear cells (2.5%).
They also report that the remaining 12.5% of tumors have a
main body with a mixed cell type.
The morphologic architecture can exhibit several
possible growth patterns including: (1) a solid pattern with
tumor cells growing densely and accompanied by a fibrous
stroma; (2) a myxoid pattern with tumor cells growing in an
insular, trabecular, and sporadic manner in an abundant
myxoid matrix; (3) a reticular pattern with a trabecular
structure of tumor cells against a backdrop of myxoid or
hyaline matrix; and (4) a mixture of these three growth
pattern types. About 60% of myoepithelioma tumors have a
solid growth pattern. Our case showed about 80% solid
pattern and about 20% myxoid pattern.ma of the upper lip, Journal of Dental Sciences (2013), http://
Figure 2 (A) T1-weightedmagnetic resonance imaging (MRI), showing that the tumorwas heterogeneously enhanced. (B) T2-weighted
MRI scan, showing that the tumor had a heterogeneous, predominantly increased signal and internal septa of low signal isointensity.
Figure 3 (A) Photograph showing the tumor covered by a fibrous capsule (40 magnification). (B) Clear cell and epithelial cells
with a myxoid matrix (100 magnification). (C) A very small number of nuclear mitoses can be seen (400 magnification). All
hematoxylin-eosin stain.
Table 1 A profile of immunohistochemical markers staining positive or negative in the tumor tissue.
Antibody (clone) Immunoglobulin isotype Antigen retrieval Immunoreactivity Source
S-100 protein Rabbit, polyclonal Autoclave, pH 6.0 Positive Nichivei
Cytokeratin (AE1/AE3) Mouse, IgGK Trypsin Positive Nichivei
Cytokeratin (CAM 5.2) Mouse, IgG2a Trypsin Positive Becton-Dickinson
CK 7 (OV-TL12/30) Mouse, IgG1 Autoclave, pH 6.0 Positive Zymed
Vimentin (sp 20) Rabbit, IgG Autoclave, pH 6.0 Positive Nichivei
Calponin (CALP) Mouse, IgG1K Trypsin Positive DAKO
p63 (4a4) Mouse, IgG2a,K Autoclave, pH 6.0 Negative DAKO
a-smooth muscle antigen (1A4) Mouse, IgM,K Autoclave, pH 6.0 Negative DAKO
Myoepithelioma of the upper lip 3
+ MODEL
Please cite this article in press as: Tachibana H, et al., Myoepithelioma of the upper lip, Journal of Dental Sciences (2013), http://
dx.doi.org/10.1016/j.jds.2013.02.020
Figure 4 Immunohistochemical findings. The tumor cells are positive for S-100 protein, AE1/AE3, CAM5.2, CK7, vimentin, and
calponin. Original magnifications 200.
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express cytokeratin and a-smooth muscle actin and S-100
protein. However, the frequently intensity of positiveFigure 5 Immunohistochemical finding. The Ki-67 labeling
index is about 3%. Original magnifications 100.
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terized by spindle cells often show a weak expression of
cytokeratin but a strong expression of a-smooth muscle
actin. By contrast, plasmacytoid and epithelioid or
epithelial cells clearly express cytokeratin, but very few
express a-smooth muscle actin. Clear cells exhibit weak
expression of both molecules. Thus, one cannot reject a
diagnosis of myoepithelioma in patients without an exten-
sive expression of a-smooth muscle actin. From an immu-
nohistologic standpoint, the S-100 protein is a significant
and important marker in the diagnosis of myoepithelioma
because a high percentage of tumor cells stain positive for
this protein.
In the present case, the tumor was positive for cyto-
keratins (AE1/AE3, CAM5.2, and CK7), vimentin, calponin,
and S-100 protein, but negative for a-smooth muscle actin
and p63. We made a diagnosis of myoepithelioma because
histologic examination showed a scattered mixture of clear
cells and epithelial cells with a myxoid matrix and a clear
boundary between the parenchyma and stroma. This tumorma of the upper lip, Journal of Dental Sciences (2013), http://
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main body of the tumor consisted of epithelioid or epithe-
lial cells that contained few positive smooth muscle cells.
We found no clear ductal structures or chondroid profile as
is seen in pleomorphic adenoma. The cellular morphology
was diverse, and there was no sign of separation of the
neoplastic myoepithelial cells into the stroma. No cellular
atypia was recognized. The Ki-67 labeling rate was
approximately 3%, and growth was localized.
Because the mitotic activity was found in one region on
rapid pathologic examination during surgery, the tumor was
excised with a safety margin of approximately 5 mm. The
patient’s clinical course was uneventful. However, further
periodic follow-up must be carried out because a case of
recurrence has been reported 24 years after removal of
such a tumor.15References
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